Erik Schwiebert

Director, Biotech Accelerator

Erik is a human cell physiologist and pathophysiologist by training. In this new role, Erik has one foot back in academia working with UAB and SR on basic science projects focused on the early stages of drug discovery and the other foot in applied science commercialization of these projects into new ventures seeded by strong therapeutic assets and technologies. Erik has devoted equal portions of his 35-year career to basic and applied science in academia and in applied and translational science in the life sciences and biotechnology industry. He trained at Dartmouth and Johns Hopkins in diseased versus normal human cell signaling with a focus on ion channel and receptor channel function. Erik is excited to be back in early-stage life sciences and biotechnology activities.